BridgeBio Stock Forecast & Price Target
BridgeBio Stock
Price Forecast
The average stock forecast for
BridgeBio Pharma Inc (BBIO) in the next 12 months is 106.33 USD. This price target corresponds to an upside
of
26.56%. The range of stock forecasts for BridgeBio is 80.80 - 164.85 USD.
Based on the ratings of 30 analysts, the consensus recommendation for BridgeBio is
BUY.
| Target |
Low |
Average |
Median |
High |
| Price (USD) |
80.80 |
106.33 |
103.02 |
164.85 |
| Upside |
-3.83% |
26.56% |
22.61% |
96.20% |
Recommendation Trends
The latest consensus rating for BridgeBio is "BUY". This is the average
recommendation of 30 analysts: 0 strong sell,
0 sell, 2 hold, 20 buy, 8 strong buy. In the previous period, 29 analysts also majorly recommmended
"BUY" for BridgeBio.
BridgeBio Financial Stock
Forecast
Revenue This Year
from 502.08M
Revenue Next Year
from 996.68M